MetGen Overview

  • Year Founded
  • 2008

Year Founded

  • Status
  • Private

  • Employees
  • 21

Employees

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 8

MetGen General Information

Description

Producer of novel enzymatic products intended to enhance the pre-treatment of a variety of lingo-cellulosic biomasses in an industry. The company's products utilize laccases or copper-containing oxidase enzymes which facilitate oxidative functions and help to accelerate chemical reactions, resulting in significant efficiency improvements in the pulp, paper, and biofuels industries, as in the removal of toxic micro-pollutants from wastewater, enabling clients to promote safe food, maintain clean environments, optimize water, energy use as well as improve operational efficiencies.

Contact Information

Website
www.metgen.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rakentajantie 26
  • 20780 Kaarina
  • Finland
+358 02
Primary Industry
Industrial Chemicals
Other Industries
Environmental Services (B2B)
Specialty Chemicals
Vertical(s)
CleanTech, Climate Tech
Corporate Office
  • Rakentajantie 26
  • 20780 Kaarina
  • Finland
+358 02

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

MetGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
9. Secondary Transaction - Private Completed Generating Revenue
8. Later Stage VC 23-Feb-2018 Completed Generating Revenue
7. Later Stage VC 22-Dec-2017 Completed Generating Revenue
6. Later Stage VC 15-Sep-2017 Completed Generating Revenue
5. Later Stage VC 25-Feb-2016 Completed Generating Revenue
4. Grant 01-Jan-2015 Completed Generating Revenue
3. Later Stage VC 04-Jun-2013 Completed Generating Revenue
2. Later Stage VC 11-Feb-2013 $2.95M $2.95M Completed Generating Revenue
1. Grant 01-Jan-2010 $43.5K Completed Generating Revenue
To view MetGen’s complete valuation and funding history, request access »

MetGen Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
B shares
B shares
Ordinary 9,121 $67.82 $67.82 1x $67.82 4.49%
To view MetGen’s complete cap table history, request access »

MetGen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Producer of novel enzymatic products intended to enhance the pre-treatment of a variety of lingo-cellulosic biomasses in
Industrial Chemicals
Kaarina, Finland
21 As of 2025

Cardiff, United Kingdom
 

Boulder, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

MetGen Competitors (5)

One of MetGen’s 5 competitors is Biocatalysts, a Corporate Backed or Acquired company based in Cardiff, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Biocatalysts Corporate Backed or Acquired Cardiff, United Kingdom
DMC Biotechnologies Venture Capital-Backed Boulder, CO
Anellotech Venture Capital-Backed Pearl River, NY
Element Solutions (Specialty Chemicals) Corporation Fort Lauderdale, FL
Anatrace Private Equity-Backed Maumee, OH
You’re viewing 5 of 5 competitors. Get the full list »

MetGen Patents

  • 87

    Total Documents Applications and Grants

  • Total Patents Families

  • 72

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

MetGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4305241-A1 Process for improving moisture- and water-resistance of paper Pending 11-Mar-2021
US-20240301629-A1 Process for improving moisture- and water-resistance of paper Pending 11-Mar-2021
EP-4127313-A1 Method for making moisture-resistant paper Pending 26-Mar-2020
US-12325958-B2 Method for making moisture-resistant paper Active 26-Mar-2020
US-20230133654-A1 Method for making moisture-resistant paper Active 26-Mar-2020 D21H17/23
To view MetGen’s complete patent history, request access »

MetGen Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MetGen Investors (8)

Investor Name Investor Type Holding Investor Since Participating Rounds
Ecolab Corporation Minority
Innovestor Venture Capital Minority
Horizon 2020 Government
Eagle Filters Group Venture Capital Minority
Finnvera Lender/Debt Provider Minority
You’re viewing 5 of 8 investors. Get the full list »

Ready to get started?

Request a free trial

MetGen FAQs

  • When was MetGen founded?

    MetGen was founded in 2008.

  • Where is MetGen headquartered?

    MetGen is headquartered in Kaarina, Finland.

  • What is the size of MetGen?

    MetGen has 21 total employees.

  • What industry is MetGen in?

    MetGen’s primary industry is Industrial Chemicals.

  • Is MetGen a private or public company?

    MetGen is a Private company.

  • What is MetGen’s current revenue?

    The current revenue for MetGen is .

  • How much funding has MetGen raised over time?

    MetGen has raised $7.93M.

  • Who are MetGen’s investors?

    Ecolab, Innovestor, Horizon 2020, Eagle Filters Group, and Finnvera are 5 of 8 investors who have invested in MetGen.

  • Who are MetGen’s competitors?

    Biocatalysts, DMC Biotechnologies, Anellotech, Element Solutions (Specialty Chemicals), and Anatrace are competitors of MetGen.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »